Becton, Dickinson and Co. (BDX) Financials
Key financial figures for Becton, Dickinson and Co. (Q4 2026).
BD Q4 FY2026 revenue rose 5.4% to $5,274M with adjusted diluted EPS from continuing operations of $4.15 (up 27.3%); FY2027 adjusted EPS guided to $13.10 to $13.30. Q4 revenue of $5,274M grew 5.4% as reported and 5.6% currency-neutral versus $5,005M; all four segments grew: Interventional +7.6%, BioPharma Systems +6.5%, Medical Essentials +5.9%, Connected Care +1.6% reported (+2.1% FXN). GAAP diluted EPS from continuing operations was $2.52 versus $1.20 a year earlier; adjusted diluted EPS from continuing operations was $4.15 versus $3.26. Operating income was $1,032M versus $536M. Within Connected Care, Medication Management Solutions revenue fell 2.3% (US -5.6%) while Advanced Patient Monitoring grew 15.0% (17.3% FXN). On the outlook: FY2027 guidance as of November 5, 2026: GAAP revenue growth low single-digit; revenue growth FXN low single-digit (illustrative FX impact of about negative 70 basis points); adjusted diluted EPS $13.10 to $13.30, which the release shows as +3.1% to +4.7% versus FY2026 adjusted diluted EPS of $12.70. Figures are for Q4 FY2026, as Becton, Dickinson and Company reported them.
- Revenue
- $5.3B
- Net Income
- $696M
- EPS
- $2.55
- Total Assets
- $50.8B
- Operating Cash Flow
- $1.5B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q4 FY2026 | $5.3B | $696M | $2.54 | 19.57% | $1.2B |
| Q3 FY2026 | $5.0B | $377M | $1.37 | 13.31% | $509M |
| Q2 FY2026 | $4.7B | -$311M | -$1.11 | 1.99% | $546M |
| Q1 FY2026 | $5.3B | $382M | $1.34 | 11.31% | $549M |
| Q4 FY2025 | $5.9B | $493M | $1.72 | 11.83% | $1.0B |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2026 | $19.5B | $1.1B | $4.09 | 11.59% | $2.9B |
| FY2025 | $21.8B | $1.7B | $5.82 | 11.8% | $2.7B |
| FY2024 | $20.2B | $1.7B | $5.86 | 11.88% | $3.1B |
Frequently asked questions
What was Becton, Dickinson and Company's revenue last quarter?
Becton, Dickinson and Company reported revenue of $5.27 billion for Q4 FY2026, down 10.5% from the same period a year earlier.
Is Becton, Dickinson and Company profitable?
Yes. Becton, Dickinson and Company reported net income of $696.0 million for Q4 FY2026, a net margin of 13.2% on revenue.
How has Becton, Dickinson and Company's margin trended?
Operating margin was 19.57% in Q4 FY2026, compared with 11.83% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Becton, Dickinson and Company generate?
Becton, Dickinson and Company generated free cash flow of $1.21 billion in Q4 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Becton, Dickinson and Co. on SentiSense, with up to forty quarters and twenty fiscal years of history.